Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Active, not recruiting · NCT04975737 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Phase 3 | 2026-07-06 | NCT04975737 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City hospital #40 | Saint Petersburg | Russia | 1 |